Largest-Ever Study of Prostate Cancer Genomics in Black Men IDs Potential Targets for Precision Therapies
None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black Americans from benefiting from a new generation of precision prostate cancer therapies, researchers say, as long as the therapies are applied equitably.